ArticleThe Journal of dermatology2025

Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center Experience.

Viviane Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.